<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Effect of selected medicines and other agents on bladder function</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Effect of selected medicines and other agents on bladder function</h1>
<div class="graphic"><div class="figure"><div class="ttl">Effect of selected medicines and other agents on bladder function</div><div class="cntnt"><table cellspacing="0"><colgroup width="20%"></colgroup><colgroup span="2" width="40%"></colgroup> <tbody> <tr> <td class="subtitle1"> </td> <td class="subtitle1">Medicines and other agents</td> <td class="subtitle1">Effect on bladder function</td> </tr> <tr> <td class="subtitle2_left" colspan="3">Allergy</td> </tr> <tr> <td class="indent1">Antihistamines</td> <td>First-generation H<sub>1 </sub>receptor antagonists (eg, brompheniramine, chlorpheniramine, clemastine, cyproheptadine, dimenhydrinate, diphenhydramine, hydroxyzine, others)</td> <td>Decreased contractility via anticholinergic effect</td> </tr> <tr class="divider_bottom"> <td class="indent1">Decongestants</td> <td>Pseudoephedrine, phenylephrine</td> <td>Increased urethral sphincter tone</td> </tr> <tr> <td class="subtitle2_left" colspan="3">Analgesic and sedative</td> </tr> <tr> <td class="indent1">Benzodiazepines</td> <td>Chlordiazepoxide, clonazepam, temazepam, triazolam, others</td> <td>Impaired micturition via muscle relaxant effect</td> </tr> <tr class="divider_bottom"> <td class="indent1">Opioids</td> <td>Codeine, meperidine, morphine, oxycodone, others</td> <td>Decreased sensation of fullness and increased urethral sphincter tone</td> </tr> <tr> <td class="subtitle2_left" colspan="3">Anticholinergic*</td> </tr> <tr> <td class="indent1">Antimuscarinics (overactive bladder medications)</td> <td>Darifenacin, fesoterodine, oxybutynin, solifenacin, tolterodine, trospium</td> <td>Decreased contractility via anticholinergic effect</td> </tr> <tr> <td class="indent1">Spasmolytic</td> <td>Dicyclomine, hyoscyamine, glycopyrrolate, methscopolamine, propantheline, scopolamine (hyoscine)</td> <td>Decreased contractility via anticholinergic effect</td> </tr> <tr class="divider_bottom"> <td class="indent1">Anticholinergics (antiparkinson medications)</td> <td>Benztropine, trihexyphenidyl</td> <td>Decreased contractility via anticholinergic effect</td> </tr> <tr> <td class="subtitle2_left" colspan="3">Cardiology<sup>¶</sup></td> </tr> <tr> <td class="indent1">ACE inhibitors</td> <td>Enalapril, lisinopril, ramipril, others</td> <td>Decreased contractility; chronic coughing</td> </tr> <tr> <td class="indent1">Alpha-agonists</td> <td>Midodrine, phenylephrine, vasopressors (various)</td> <td>Increased urethral sphincter tone</td> </tr> <tr> <td class="indent1">Alpha<sub>1</sub>-blockers</td> <td>Alfuzosin, doxazosin, prazosin, silodosin, tamsulosin, terazosin</td> <td>Decreased urethral sphincter tone</td> </tr> <tr> <td class="indent1">Antiarrhythmic</td> <td>Disopyramide, flecainide</td> <td>Decreased contractility via local anesthetic effect on bladder mucosa or anticholinergic effect</td> </tr> <tr class="divider_bottom"> <td class="indent1">Diuretics</td> <td>Various</td> <td>Increased urine production, contractility, or rate of emptying</td> </tr> <tr> <td class="subtitle2_left" colspan="3">Psychotropic</td> </tr> <tr> <td class="indent1" rowspan="2">Antidepressants</td> <td>SNRIs: duloxetine, reboxetine<sup>Δ</sup></td> <td>Increased urethral sphincter tone</td> </tr> <tr> <td>Tricyclic antidepressants (amitriptyline, clomipramine, desipramine, doxepin, imipramine, nortriptyline, others)</td> <td>Decreased contractility via anticholinergic effect</td> </tr> <tr class="divider_bottom"> <td class="indent1">Antipsychotics</td> <td>First-generation (chlorpromazine, fluphenazine, methotrimeprazine); second-generation (clozapine, olanzapine, risperidone); others have lower effect</td> <td>Mixed effects described; decreased contractility via anticholinergic effect; increased micturition and stress incontinence via stimulation of alpha<sub>1</sub> receptors and/or central dopaminergic receptors</td> </tr> <tr> <td class="subtitle2_left" colspan="3">Other</td> </tr> <tr> <td class="indent1">Skeletal muscle relaxants</td> <td>Orphenadrine, tizanidine (also cyclobenzaprine, baclofen, and methocarbamol; but effect is lower)</td> <td>Decreased contractility via anticholinergic effect</td> </tr> <tr> <td class="indent1">Estrogens</td> <td>Oral estrogens (hormone replacement therapy)</td> <td>Increased urinary incontinence</td> </tr> <tr> <td class="indent1">Beta<sub>3</sub>-agonist</td> <td>Mirabegron</td> <td>Decreased contractility via beta<sub>3</sub>-adrenergic effect</td> </tr> <tr> <td class="indent1">Alcohol</td> <td> </td> <td>Decreased contractility</td> </tr> <tr> <td class="indent1">Caffeine</td> <td> </td> <td>Increased contractility or rate of emptying</td> </tr> </tbody></table></div><div class="graphic_footnotes">ACE: angiotensin-converting enzyme; SNRIs: serotonin-norepinephrine reuptake inhibitors; BPH: benign prostatic hyperplasia.<br/>* Inhaled antimuscarinic bronchodilators (eg, ipratropium, tiotropium) and ophthalmic drops (eg, atropine, cyclopentolate) can be absorbed systemically in varying degrees; urinary retention has been rarely associated with their use particularly among older adults, among men with BPH, and with administration of an inhaled anticholinergic drug by nebulizer. <br/>¶ Increased micturition reported by ≤3% of patients in clinical studies of calcium channel blockers; mixed effects have been described. <br/>Δ Not available in the United States.</div><div class="graphic_reference">Prepared with data from:

<ol>
<li>Verhamme K, Sturkenboom M, Stricker B, et al. Drug induced urinary retention. Drug Saf 2008; 31:373.</li>
<li>Zyczynski H, Parekh M, Kahn M, et al. Urinary incontinence in women. American Urogynecologic Society (2012); available at http://eguideline.guidelinecentral.com/i/76622-augs-urinary-incontinence</li>
</ol></div><div id="graphicVersion">Graphic 101070 Version 4.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
